Skip to main content
Viking Therapeutics, Inc. logo

Viking Therapeutics, Inc. — Investor Relations & Filings

Ticker · VKTX ISIN · US92686J1060 LEI · 529900IVC72YPFA25M37 US Professional, scientific and technical activities
Filings indexed 608 across all filing types
Latest filing 2024-11-09 Regulatory Filings
Country US United States of America
Listing US VKTX

About Viking Therapeutics, Inc.

https://vikingtherapeutics.com/

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel therapies for patients suffering from metabolic and endocrine disorders. The company's pipeline is centered on small molecule drug candidates designed to address these conditions.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2024
Regulatory Filings
2024-11-09 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-11-04 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce specific events or disclosures. The text indicates it is a Current Report pursuant to the Securities Exchange Act of 1934, dated November 4, 2024. The content describes a press release announcing clinical trial results and includes a Regulation FD disclosure. There are no comprehensive financial statements or detailed financial performance data typical of Annual Reports (10-K) or Interim Reports (IR). The document is not a transcript, audit report, or management report. It is a regulatory filing announcing a specific event (clinical trial results) and furnishing a press release as an exhibit. The document length is 3731 characters, which is relatively short and consistent with an 8-K current report. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories.
2024-11-04 English
4
Director's Dealing
2024-10-29 English
Regulatory Filings 2024
Regulatory Filings
2024-10-28 English
4
Director's Dealing
2024-10-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.